Read article – Continued coverage of comments by Lisa Marsch, director of the Center for Technology and Behavioral Health and professor of psychiatry and of the Dartmouth Institute for Health Policy and Clinical Practice, about research she led examining why New Hampshire’s opioid problem is so dire.

Read article – An opinion piece that comments on a New York Times story about one family’s struggle with addiction, and cites the work of researchers at Dartmouth’s Geisel School of Medicine in helping to explain why New Hampshire’s opioid problem is so dire. The Granite State ranks second behind West Virginia in opioid deaths – nearly 500 people died from overdoses in 2015 and 2016 – and first in the nation in deaths due to fentanyl.

Read article – Quotes H. Gilbert Welch, professor of medicine and of the Dartmouth Institute for Health Policy and Clinical Practice, from an opinion piece previously published in The New York Times, which discussed the stricter guidelines from the American Heart Association and the American College of Cardiology.

Read article – Quotes David Jevsevar, chair and assistant professor of orthopaedics, about how a joint replacement may not eliminate all pain or restore full range of motion in a hip or knee. “We can’t take someone who is doing awful and suddenly make them perfect,” says Jevsevar.

Read article – A feature story about the 11th annual C. Everett Koop Addiction Medicine Symposium, which focused on the theme “Harm Reduction in an Opioid Era.” The article highlights conference speakers Louisa Chen, Geisel ’20, and Nasim Azizgolshani, Geisel ’20, who started a safe syringe program in Claremont, N.H., last year. Chen and Azizgolshani said that such programs can prevent the spread of diseases such as HIV and Hepatitis C, and connect drug users with critical services, including treatment. The article also quotes Charles Brackett, assistant professor of medicine and of the Dartmouth Institute for Health Policy and Clinical Practice, about how New Hampshire has the nation’s second-highest rate of fatal overdoses. (Similar coverage in the Valley News and the New Hampshire Union Leader.)

Read article – Continued coverage of comments by Lisa Marsch, director of the Center for Technology and Behavioral Health and professor of psychiatry and of the Dartmouth Institute for Health Policy and Clinical Practice, about research she led examining why New Hampshire’s opioid problem is so dire. (Similar coverage in The Washington Post.)

Read article – Quotes Lucia Joseph, Geisel ’20, who attended the sixth annual regional conference of Physicians for Human Rights, which focused on gender-based abuse. “It’s good that there are events like this conference,” says Joseph. “Sure, it’s hard to keep up with classwork and labs and still get sleep and exercise, but conferences like this are an excellent way to remember that there’s a life outside medical school, and to find out about how to take care of people.”

Read article – Quotes Lisa Marsch, director of the Center for Technology and Behavioral Health and professor of psychiatry and of the Dartmouth Institute for Health Policy and Clinical Practice, about research she led examining why New Hampshire’s opioid problem is so dire. “We have highly available, highly potent opioids in New Hampshire,” says Marsch. “And highly limited resources to reduce the risk.”

Read article – Quotes Lisa Schwartz, director of the Center for Technology and Behavioral Health and professor of psychiatry and of the Dartmouth Institute for Health Policy and Clinical Practice, in an article discussing the pitfalls of cancer screening. “For many cancers, we’re not good at distinguishing which will be dangerous and which won’t,” says Schwartz. “If these cancers don’t actually go on to progress, the treatment is pure harm.” (Picked up by Popular Science Australia.)